The multi-xenobiotic resistance phenotype as a tool to biomonitor the environment

Biomarkers

Volumn 4, Issue 6, 1999, Pages 442-454

  Minier, Christophe ^a   Eufemia, Nancy ^b   Epel, David ^b  

^a UNIVERSITÉ DU HAVRE   (France)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Biomarker; Bivalve; Drug resistance; Mussel; MXR; P glycoprotein

Indexed keywords

BIOCHEMICAL MARKER; EMETINE; FORSKOLIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; N (2 FLUORENYL)ACETAMIDE; QUINIDINE; RHODAMINE; TRIFLUOPERAZINE; VERAPAMIL; VINBLASTINE; VINCRISTINE;

BIOLOGICAL MONITORING; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; MULTIDRUG RESISTANCE; MUSSEL; NONHUMAN; PHENOTYPE; PROTEIN INDUCTION;

BIVALVIA;

EID: 0032783806     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475099230606     Document Type: Conference Paper

References (89)

1. ABOUHAMAD, W. N., MANSON, M., GIBSON, M. and HIGGINS, C. F. 1991, Peptide transport and chemotaxis in Echerischia coli and Salmonella typhimurium: characterization of the dipeptide permease (Dpp) and the dipeptide-binding protein. Molecular Microbiology 5, 1035-1047.
2. AMES, G. F. L., MIMURA, C. S. and SHYAMALA, V. 1990, Bacterial periplasmic permeases belong to a family of transport proteins operating from Escherichia coli to human: traffic ATPases. FEMS Microbiology Reviews, 75, 429-446.
3. BECK, W. T., CIRTAIN, M. C., DANKS, M. K., FELSTED, R. L., SAFA, A. R., WOLVERTON, J. S., PARKER, SUTTLE, D. and TRENT, J. 1987, Pharmacological, molecular and cytogenetic analysis of 'atypical' multidrug-resistant human leukemic cells. Cancer Research, 47, 5455-5460.
4. BROEKS, A., JANSSEN, H. W. R. M., CALAFAT, J. and PLASTERK, R. H. A. 1995, A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO Journal, 14, 1858-1866.
5. CALLAHAN, H. L. and BEVERLEY, S. M. 1991, Heavy metal resistance: a new role for P-glycoprotein in Leishmania. Journal of Biological Chemistry, 266, 18427-18430.
6. CHAN, K. M., DAVIES, P. L., CHILDS, S., VEINOT, L. and LING, V. 1992, P-glycoprotein genes in the winter flounder, Pleuronectes americanus: isolation of two types of genomic clones carrying 3′ terminal exons. Biochemica et Biophysica Acta, 1171, 65-72.
7. CHIN, K. V., TANAKA, S., DARLINGTON, G., PASTAN, I. and GOTTESMAN, M. M. 1990, Heat shock and arsenite increase expression of the multidrug-resistance (MDRI) gene in human renal carcinoma cells. Journal of Biological Chemistry, 265, 221-226.
8. COLE, S. P. C., BHARDWAI, G., GERLACH, J. H., MACKIE, J. E., GRANT, C. E., ALMQUIST, K. C., STEWART, A. J., KURZ, E. U., DUNCAK, A. M. V. and DEELEY, R. G. 1992, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
9. COLE, S. P. C., SPARKS, K. E., FRASER, K., LOE, D. W., GRAT, C. E., WILSON, G. M. and DEELEY, R. G. 1994, Pharmacological characterisation of multidrug-resistant MRP-transfected human tumor cells. Cancer Research, 54, 5902-5910.
10. CORDON-CARDO, C., O'BRIEN, J. P., BOCCIA, J., CASALS, D., BERTINO, J. R. and MELAMED, M. R. 1990, Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. Journal of Histochemistry and Cytochemistry, 38, 1277-1287.
11. CORNWALL, R., TOOMEY, B. H., BARD, S., BACON, C., JARMAN, W. M. and EPEL, D. 1995, Characterization of multixenobiotic/multidrug transport in the gills of the mussel Mytilus californianus and identification of environmental substrates. Aquatic Toxicology, 31, 277-296.
12. DANKS, M. K., YALOWICH, J. C. and BECK, W. T. 1987, Atypical multiple drug resistance in human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Research, 47, 1297-1301.
13. DANÖ, K. 1973, Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochimica et Biophysica Acta, 323, 466-483.
14. DE FLORA, S., BAGNASCO, M., BENNICELLI, C., CAMOIRANO, A., BOJINEMIRSKI, A. and KURELEC, B. 1995, Biotransformation of genotoxic agents in marine sponges. Mechanisms and modulation. Mutagenesis, 10, 357-364.
15. DOYLE, L. A., YANG, W., RISHI, A. K., GAO, Y. and ROSS, D. D. 1996, H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein. Cancer Research, 56, 2904-2907.
16. DUDLER, R. and HERTIG, C 1992, Structure of an MDR-like gene from Arabidopsis thaliana. Journal of Biological Chemistry, 267, 5882-5888.
17. ELBLING;, L., BERGER, W., REHBERGER, A., WALDHOR, T. and MICKSCHE, M. 1993, P-glycoprotein regulates chemosensitivity in early developmental stages of the mouse. FASEB Journal, 7, 1499-1506.
18. ENDICOTT, J. A. and LING, V. 1989, The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry, 58, 137-171.
19. EUFEMIA, N. A. and EPEL, D. 1998, The multixenobiotic defence mechanism in mussels is induced by substrates: implication for a general stress response. Marine Environmental Research, 46, 401-405.
20. FELMLEE, T., PELLET, S. and WELCH, R. A. 1985, Nucleotide sequence of an Escherichia coli chromosomal hemolysin. Journal of Bacteriology, 163, 94-105.
21. FERNADES, D. J., DANKS, M. K. and BECK, W. T. 1990, Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA. Biochemistry, 29, 4235-4241.
22. 12 transport in Escherichia coli and homology with components of periplasmic-binding-protein-dependant transport systems. Journal of Bacteriology, 167, 928-934.
23. GALGANI, F., CORNWALL, R., TOOMEY, B. H. and EPEL, D. 1995, Interaction of environmental xenobiotics with a multixenobiotic defense mechanism in the bay mussel Mystilus galloprovincialis from the coast of California. Environmental Toxicology and Chemistry, 15, 325-331.
24. GEORGES, E., BRADLEY, G., GARIEPY, J. and LING, V. 1990, Detection of P-glycoprotein isoforms by gone-specific monoclonal antibodies. Proceedings of the National Academy of Sciences USA, 87, 152-156.
25. GILSON, L., MAHANTY, H. K. and KOLTER, R. 1990, Genetic analysis of an MDR-like export system: the secretion of colicin V. EMBO Journal, 7, 3971-3974.
26. GOTTESMAN, M. M. and PASTA, I. 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385-427.
27. GRANT, C. E., VALDIMARSSON, G., HIPFNER, D. R., ALMQUIST, K. C., COLE, S. P. C. and DEELEY, R. G. 1994, Overexpression of multidrug-resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Research, 54, 357-361.
28. GROS, P., BEN NERIAH, Y., CROOP, J. M. and HOUSMAN, D. E. 1986, Isolation and expression of a cDNA (MDR) that confers multidrug resistance. Nature (London), 323, 728-731.
29. GUEIROS, FILHO F. J., VIOLA, J. P., GOMES, F. C., FARINA, M., LINS, U., BERTHO, A. L., WIRTH, D. F. and LOPES, U. G. A. D. 1995, Leishmania amazonensis: multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux. DNA amplification, and RNA overexpression of a Leishmania MDR1 gene. Experimental Parasitology, 81, 480-490.
30. GUILD, B. C., MULLIGAN, R. C., GROS, P. and HOUSMAN, D. E. 1988, Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proceedings of the National Academy of Sciences USA, 85, 1595-1599.
31. HEMMER, M. J., COURTNEY, L. A. and ORTEGO, L. S. 1995, Immunohistochemical detection of P-glycoprotein in teleost tissues using mammalian polyclonal and monoclonal antibodies. Journal of Experimental Zoology, 272, 69-77.
32. HIGGINS, C. E. and GOTTESMAN, M. M. 1992, Is the multidrug transporter a 'Hipase'? Trends in Biochemical Science, 17, 18-19.
33. HIGGINS, C. F. 1992, ABC transporters: from microorganisms to man. Annual Review of Cell Biology, 8, 67-113.
34. HIGGINS, C. F., HILES, I. D., SALMOND, G. P. C., GILL, D. R., DOWNIE, J. A., EVANS, I. J., HOLLAND, I. B., GRAY, L., BUCKELS, D., BELL, A. W. and HERMODSON, M. A. 1986, A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature (London) 323, 448-450.
35. HIPENER, D. R., GAULDIE, S. D., DEELEY, R. G. and COLE, S. P. C. 1994, Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Research 54, 5788-5792.
36. HOBAN, P. R., ROBSON, C. N., DAVIES, S. M., HALL, A. G., CATAN, A. R., HICKSON, I. D. and HARRIS, A. L. 1992, Reduced topoisomerase II and elevated class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C. Biochemical Pharmacology 43, 685-693.
37. HOMOLYA, L., HOLLO, Z., GERMANN, U. A., PASTAN, I., GOTTESMAN, M. M. and SARKADI, B. 1993, Journal of Biological Chemistry, 268, 21493-21496.
38. HYDE, S. C., EMSLEY, P., HARTSHORN, M., MIMMACK, M. M. and GILEADI, U. 1990, Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature, 346, 362-365.
39. JULIANO, R. I. and LING, V. 1976, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica 455, 152-162.
40. KOHLEK, A., LAURITZEN, B., JANSEN, D., BOTTCHER, P., TEGULIWA, L., KRÜNER, G. and BROEG, K. 1998a, Detection of P-glycoprotein mediated MDR/MXR in Carcinus maenas hepatopancreas by immuno-gold-silver labeling. Marine Environmental Research, 46, 411-414.
41. KÖHLER, A., LAURITZEN, B., JANSEN, D., BAHNS, S., GEORGE, C. G., FÖRLIN, L. and VAN NOORDEN, C. J. F. 1998b, Clonal adaptation of cancer cells in flatfish liver to environmental contamination by changes in expression of P-gp related MXR, CYP450, GST-A and G6PDH activity. Marine Environmental Research, 46, 191-195.
42. KRISHNAMACHARY, N. and CENTER, M. S. 1993, The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Research 53, 3658-3661.
43. KRUH, G. D., CHAN, A., MYERS, K., GAUGHAN, K., MIKI, T. and AARONSON, S. A. 1994, Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Research, 54, 1649-1652.
44. KURELEC, B. 1992, The multixenobiotic resistance mechanism in aquatic organisms. Critical Review in Toxicology, 19, 291-302.
45. KURELEC, B. 1995, Reversion of multixenobiotic resistance mechanism in gills of a marine mussel Mytilus galloprovincialis by model inhibitor and environmental modulators of P170-glycoprotein. Aquatic Toxicology, 33, 93-103.
46. KURELEC, B., KRCA, S., PIVCEVIC, B., UGARKOVIC, D., BACHMANN, M., IMSIECKE, G. and MÜLLER, W. E. G. 1992, Expression of P-glycoprotein gene in marine sponges. Identification and characterization of the 125 KDa drug-binding glycoprotein. Carcinogenesis, 13, 69-76.
47. KURELEC, B., LUCIE, PIVCEVIC, B. and KRCA, S. 1995a, Induction and reversion of multixenobiotic resistance in the marine snail Monodonta turbinata. Marine Biology, 123, 305-312.
48. KURELEC, B., PIVCEVIC, B. and MÜLLER, W. E. G. 1995b, Determination of pollutants with multixenobiotic resistance inhibiting properties. Marine Environmental Research, 39, 261-265.
49. KURELEC, B., KRCA, S. and LUCIC, D. 1996a, Expression of multixenobiotic resistance mechanism in a marine mussel Mytilus galloprovincialis as a biomarker of exposure to polluted environment. Comparative Biochemistry and Physiology, 113C, 283-289.
50. KURELEC, B., WALDMANN, P. and ZAHN, R. K. 1996b, The modulation of protective effects of multixenobiotic resistance mechanism in a clam Corbicula fluminea. Marine Environmental Research, 42, 383-387.
51. KURELEC, B., BRITVLE, S., PIVEEVLE, B. and SMITAL, T. 1998, Fragility of multixenobiotic resistance in aquatic organisms enhances the complexity of risk assessment. Marine Environmental Research, 46, 415-419.
52. MCGRATH, J. P. and VARSHAVSKY, A. 1989, The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature (London), 340, 400-404.
53. MICHIELI, M., DAMIANI, D., ERMACORA, A., RASPADORI, D., MICHELUTTI, A., GRIMAZ, S., FANIN, R., RUSSO, D., LAURIA, F., MASOLINI, P. and BACCARANI, M. 1997, P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. British Journal of Haematology, 96, 356-365.
54. MINIER, C. 1994, Non-specific esterase activity and MXR as biomarkers for the assessment of biological effects in marine organisms. PhD thesis, University of Nantes (France), 153 pp.
55. MINIER, C. and MOORE, M. N. 1996, Rhodamine B accumulation and mxr protein expression in mussel blood cells: effects of exposure to vincristine. Marine Ecology Progress Series, 142, 165-173.
56. MINIER, C. and MOORE, M. N. 1998, Calcein accumulation in mussel blood cells. Marine Environmental Research, 46, 425-428
57. MINIER, C., AKCHA, F. and GALGANI, F. 1993, P-glycoprotein expression in Crassostrea gigas and Mytilus edulis in polluted seawater. Comparative Biochemistry and Physiology, 106, 1029-1036.
58. MINIER, C., BORGHI, V. and PORTE, C. 1999, Seasonal variation of MXR and stress proteins of the common mussel, Mytilus galloprovincialis. (In press).
59. MOORE, M. N. and WILLOWS, R. I. 1998, A model for cellular uptake and intracellular behaviour of particulate-bound micropolluants. Marine Environmental Research, 46, 509-514.
60. MÜLER, K. M., EBENSPERGER, C. and TAMPÉ, R. 1994, Nucleotide binding to the hydrophylic c-terminal domain of the transporter associated with antigen processing (TAP). Journal of Biological Chemistry, 269, 14032-14037.
61. MÜLLER, M., MEIJER, C., ZAMAN, G. J. R., BORST, P., SCHEPPER, R. J., MULDER, N. M., DE VRIES, A. G. E. and JANSEN, P. L. M. 1994, Overexpression of the gene encoding the multidrug resistance-associated protein result in increased ATP-dependent glutathione-S-conjugate transport. Proceedings of the National Academy of Sciences USA, 91, 13033-13037.
62. NG, W. F., SARANGI, F., ZASTAWNY, R. L., VEINOT-DREBOT, L. and LING, V. 1989, Identification of members of the P-glycoprotein multigene family. Molecular and Cellular Biology, 9, 1224-1232.
63. OHYAMA, K., FURKUZAWA, H., KOCHI, T., SHIRAI, H. and SANO, T. 1986, Chloroplast geneorganization deduced from complete sequence of liverwort. Marchantia polymorpha chloroplast DNA. Nature, 332, 572-574.
64. POMMIER, Y., KERRIGAN, D., SCHWARTZ, R. E., SWACK, J. A. and MCCURDY, A. 1986, Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Research, 46, 3075-3080.
65. QIAN, X. and BECK, W. T. 1990, Progesterone photoaffinity labels P-glycoprotein in multidrug-resistant human leukemic lymphoblasts. Journal of Biological Chemistry, 265, 18753-18756.
66. RIORDAN, J. R., ROMMENS, J. M., KEREM, B., ALON, N., ROZMAHEL, R., GRZELCZAK, Z., LOK, S., PLAVSIC, N., CHOU, J. L., DRUM, M. L., IANNUZZI, M. C., COLLINS, F. S. and TSUI, L. C. 1989, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 245, 1066-1073.
67. ROEPE, P. D. 1995, The role of the MDR protein in altered drug translocation across tumor cell membranes. Biochim et Biophysica Acta 1241, 385-406.
68. SCHEPER, R. J., BROXTERMAN, H. J., SCHEFFER, G. L., KAAIJK, P. and DALTON, W. S. 1993, Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Research, 53, 1475-1479.
69. SCHINKEL, A. H., MAYER, U., WAGENAAR, E., MOL, C. A. A. M., VAN DEEMTER, L., SMIT, J. J. M., VAN DER VALK, VOORDOUW, A. C., SPITS, H., VAN TELLINGEN, O., ZIJLMANS, J. M. J. M., FIBBE, W. E. and BORST, P. 1997, Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proceedings of the National Academy of Sciences USA, 94, 4028-4033.
70. SHAPIRO, A. B. B. and LING, V. 1997, Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. European Journal of Biochemistry, 250, 130-137.
71. SIMON, S., DEBORSHI, R. and SCHINDLER, M. 1994, Intracellular pH and the control of multidrug resistance. Proceedings of the National Academy of Sciences USA, 91, 1128-1132.
72. SMITAL, T. and KURELEC, B. 1997, Inhibitors of the multixenbiotic resistance mechanism in natural waters: in vivo demonstration of their effects. Environmental Toxicology and Chemistry, 16, 2164-2170.
73. SMITAL, T. and KURELEC, B. 1998, The activity of multixenbiotic resistance mechanism determined by rhodamine B-efflux method as a biomarker of exposure. Marine Environmental Research, 46, 443-447.
74. SMITAL, T., PIVCEVIC, B. and KURELEC, B. 1996, Reversal of multidrug resistance by extract from a marine algae Caulerpa taxifolia. Period. Biol. 98, 165-171.
75. SUGAWARA, I., KATAOKA, I., MORISHITA, Y., HAMADA, H., TSURUO, T., ITOYAMA, S. and MORI, S. 1998, Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Research, 48, 1926-1929.
76. THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M. M., PASTAN, I. and WILLINGHAM, M. C. 1987, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences USA, 84, 7735-7738.
77. TOOMEY, B. H. 1996, A multixenobiotic defense mechanism in the embryos of the echiuran worm Urechis caupo. PhD thesis, Stanford University, 102 pp.
78. TOOMEY, B. H. and EPEL, D. 1993. Multidrug resistance in Urechis caupo embryos: Protection from environmental toxins. Biological Bulletin, 185, 355-364.
79. TOOMEY, B. H., KAUFMAN, M. R. and EPEL, D. 1996, Marine bacteria produce compounds that modulate multixenobiotic transport activity in Urechis caupo embryos. Marine Environmental Research, 42, 393-397.
80. TOWNSEND, A. J. and COWAN, K. H. 1989, Glutathione S-transferases and antineoplastic drug resistance. Cancer Bulletin, 41, 31-37.
81. UEDA, K., CARDARELLI, C., GOTTESMAN, M. M., and PASTAN, I. 1987, Expression of a full-length cDNA for the human MDRI gene confers resistance to colchicine, doxorubicin and vinblastine. Proceedings of the National Academy of Sciences, USA, 84, 3004-3008.
82. VEROVSKI, V. N., VAN DEN BERGE, D. L., DELVAEYE;, M. M., SCHEPER, R. J., DE NEVE, W. J. and STORME, G. A. 1996, Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion. British Journal of Cancer, 73, 596-602.
83. WALDMANN, P., PIVCEVIC, B., MÜLLER, W. E. G., ZAHN, R. K. and KURELEC, B. 1995, Increased genotoxicity of acetylaminofluorene by modulators of multixenobiotic resistance mechanism: Studies with the fresh water clam Corbicula fluminea. Mutation Research 342, 113-123.
84. WALKER, J. E., SARASTE, M., RUNSWICK, M. J. and GAY, N. J. 1982, Distantly related sequences in the α and β-subunits of ATP synthetase, myosin, kinases and other ATP requiring enzymes and a common nucleotide binding fold. EMBO J. 1: 945-951.
85. WILSON, G. M., SERRANO, A. E., WASLEY, A., BOGENSCHUTZ, M. P., SHANKAR, A. H. and WIRTH, D. F. 1989, Amplification of a gene related to mammalian MDR genes in drug-resistant Plasmodium falciparum. Science, 244, 1184-1186.
86. WU, C. T., BUDDING, M., GRIFFIN, M. S. and CROOP, J. M. 1991, Isolation and characterisation of Drosophila multidrug resistance gene homologs. Molecular and Cellular Biology, 11, 3940-3948.
87. ZAMAN, G. J. R., FLENS, M. J., VAN LEUSDEN, M. R., DE HAAS, M., MULDER, H. S., LANKELMA, J., PINEDO, H. M., SCHEPER, R. J., BAAS, F., BROXRTERMAN, H. J. and BORST, P. 1994, The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proceedings of the National Academy of Sciences USA, 91, 8822-8826.
88. ZIJLSTRA, J. G., DE VREIS, E. G. E. and MULDER, N. H. 1987, Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Research, 47, 1780-1784.
89. ZUMFT, W. G., VIERBROCK-SAMBALE, A. and BRAUN, C. 1990, Nature oxide reductase from denitrifying Pseudomonas stutzen. European Journal of Biochemistry, 192, 591-599.